130
Participants
Start Date
June 10, 2019
Primary Completion Date
May 20, 2023
Study Completion Date
May 20, 2023
Evolocumab
420 mg evolocumab will be administered subcutaneously by giving 3 injections consecutively within 30 minutes using the single-use prefilled autoinjector.
Placebo
Placebo will be administered subcutaneously by giving 3 injections consecutively within 30 minutes using the single-use prefilled autoinjector.
Department of Cardiology, Rigshospitalet, Copenhagen
Department of Cardiology, Aarhus University Hospital, Skejby
The Clinic for Heart Failure and Valvular Disease, Skåne University Hospital and Lund University, Lund
Helsinki University Hospital Heart and Lung Center, Helsinki
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg
Sahlgrenska University Hospital
OTHER
Skane University Hospital
OTHER
Rigshospitalet, Denmark
OTHER
Aarhus University Hospital
OTHER
Helsinki University Central Hospital
OTHER
Lars Gullestad
OTHER